APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gadobebe Diglumine Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gadobebe Diglumine Injection Market Outlook and Growth Opportunities 2026

Report ID 173993770427 December 2025196 pages

Choose your research edition.

Industry ResearchGadobebe Diglumine Injection Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadobebe Diglumine Injection Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Gadobebe Diglumine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadobebe Diglumine Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadobebe Diglumine Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gadobebe Diglumine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gadobebe Diglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gadobebe Diglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadobebe Diglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gadobebe Diglumine Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gadobebe Diglumine Injection market include Guerbet and Bracco Imaging S.P.A. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gadobebe Diglumine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gadobebe Diglumine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gadobebe Diglumine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gadobebe Diglumine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Gadobebe Diglumine Injection Segment by Company

Guerbet

Bracco Imaging S.P.A.

Gadobebe Diglumine Injection Segment by Type

20ml

15ml

10ml

Gadobebe Diglumine Injection Segment by Application

Hospital

Clinic

Others

Gadobebe Diglumine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gadobebe Diglumine Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gadobebe Diglumine Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gadobebe Diglumine Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Gadobebe Diglumine Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadobebe Diglumine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadobebe Diglumine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadobebe Diglumine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gadobebe Diglumine Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gadobebe Diglumine Injection industry.

Chapter 3: Detailed analysis of Gadobebe Diglumine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gadobebe Diglumine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gadobebe Diglumine Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gadobebe Diglumine Injection Industry Trends Table 2. Gadobebe Diglumine Injection Industry Drivers Table 3. Gadobebe Diglumine Injection Industry Opportunities and Challenges Table 4. Gadobebe Diglumine Injection Industry Restraints Table 5. Global Gadobebe Diglumine Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gadobebe Diglumine Injection Revenue Share by Company (2021-2026) Table 7. Global Gadobebe Diglumine Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Gadobebe Diglumine Injection Sales Volume Share by Company (2021-2026) Table 9. Global Gadobebe Diglumine Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Gadobebe Diglumine Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gadobebe Diglumine Injection Key Company Manufacturing Base & Headquarters Table 12. Global Gadobebe Diglumine Injection Company, Product Type & Application Table 13. Global Gadobebe Diglumine Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gadobebe Diglumine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20ml Table 18. Significant Companies of 15ml Table 19. Significant Companies of 10ml Table 20. Global Gadobebe Diglumine Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Gadobebe Diglumine Injection Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Gadobebe Diglumine Injection Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Gadobebe Diglumine Injection Sales Volume Share by Type (2021-2026) Table 24. Global Gadobebe Diglumine Injection Sales Volume Share by Type (2027-2032) Table 25. Global Gadobebe Diglumine Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gadobebe Diglumine Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Gadobebe Diglumine Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Gadobebe Diglumine Injection Sales Value Share by Type (2021-2026) Table 29. Global Gadobebe Diglumine Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Others Table 33. Global Gadobebe Diglumine Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Gadobebe Diglumine Injection Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Gadobebe Diglumine Injection Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Gadobebe Diglumine Injection Sales Volume Share by Application (2021-2026) Table 37. Global Gadobebe Diglumine Injection Sales Volume Share by Application (2027-2032) Table 38. Global Gadobebe Diglumine Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Gadobebe Diglumine Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Gadobebe Diglumine Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Gadobebe Diglumine Injection Sales Value Share by Application (2021-2026) Table 42. Global Gadobebe Diglumine Injection Sales Value Share by Application (2027-2032) Table 43. Global Gadobebe Diglumine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Gadobebe Diglumine Injection Sales by Region (2021-2026) & (K Units) Table 45. Global Gadobebe Diglumine Injection Sales Market Share by Region (2021-2026) Table 46. Global Gadobebe Diglumine Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Gadobebe Diglumine Injection Sales Market Share by Region (2027-2032) Table 48. Global Gadobebe Diglumine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Gadobebe Diglumine Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Gadobebe Diglumine Injection Sales Value Share by Region (2021-2026) Table 51. Global Gadobebe Diglumine Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Gadobebe Diglumine Injection Sales Value Share by Region (2027-2032) Table 53. Global Gadobebe Diglumine Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Gadobebe Diglumine Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Gadobebe Diglumine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Gadobebe Diglumine Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Gadobebe Diglumine Injection Sales by Country (2021-2026) & (K Units) Table 58. Global Gadobebe Diglumine Injection Sales Market Share by Country (2021-2026) Table 59. Global Gadobebe Diglumine Injection Sales by Country (2027-2032) & (K Units) Table 60. Global Gadobebe Diglumine Injection Sales Market Share by Country (2027-2032) Table 61. Global Gadobebe Diglumine Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Gadobebe Diglumine Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Gadobebe Diglumine Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Gadobebe Diglumine Injection Sales Value Market Share by Country (2027-2032) Table 65. Guerbet Company Information Table 66. Guerbet Business Overview Table 67. Guerbet Gadobebe Diglumine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Guerbet Gadobebe Diglumine Injection Product Portfolio Table 69. Guerbet Recent Development Table 70. Bracco Imaging S.P.A. Company Information Table 71. Bracco Imaging S.P.A. Business Overview Table 72. Bracco Imaging S.P.A. Gadobebe Diglumine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Bracco Imaging S.P.A. Gadobebe Diglumine Injection Product Portfolio Table 74. Bracco Imaging S.P.A. Recent Development Table 75. Key Raw Materials Table 76. Raw Materials Key Suppliers Table 77. Gadobebe Diglumine Injection Distributors List Table 78. Gadobebe Diglumine Injection Customers List Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Gadobebe Diglumine Injection Product Image Figure 2. Global Gadobebe Diglumine Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadobebe Diglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gadobebe Diglumine Injection Sales (2021-2032) & (K Units) Figure 5. Global Gadobebe Diglumine Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Gadobebe Diglumine Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20ml Image Figure 10. 15ml Image Figure 11. 10ml Image Figure 12. Global Gadobebe Diglumine Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Gadobebe Diglumine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Gadobebe Diglumine Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Gadobebe Diglumine Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Gadobebe Diglumine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Gadobebe Diglumine Injection Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Gadobebe Diglumine Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Gadobebe Diglumine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Gadobebe Diglumine Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Gadobebe Diglumine Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Gadobebe Diglumine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Gadobebe Diglumine Injection Sales Value Share by Application (2021-2032) Figure 27. Global Gadobebe Diglumine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Gadobebe Diglumine Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Gadobebe Diglumine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Gadobebe Diglumine Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Gadobebe Diglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Gadobebe Diglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Gadobebe Diglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Gadobebe Diglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Gadobebe Diglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Gadobebe Diglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Gadobebe Diglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Gadobebe Diglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Gadobebe Diglumine Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Gadobebe Diglumine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Gadobebe Diglumine Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Gadobebe Diglumine Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 20ml
  • 15ml
  • 10ml
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Guerbet
  • Bracco Imaging S.P.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gadobebe Diglumine Injection Sales Value (2021-2032)
  4. 1.2.2 Global Gadobebe Diglumine Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Gadobebe Diglumine Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gadobebe Diglumine Injection Market Dynamics
  1. 2.1 Gadobebe Diglumine Injection Industry Trends
  2. 2.2 Gadobebe Diglumine Injection Industry Drivers
  3. 2.3 Gadobebe Diglumine Injection Industry Opportunities and Challenges
  4. 2.4 Gadobebe Diglumine Injection Industry Restraints
3 Gadobebe Diglumine Injection Market by Company
  1. 3.1 Global Gadobebe Diglumine Injection Company Revenue Ranking in 2025
  2. 3.2 Global Gadobebe Diglumine Injection Revenue by Company (2021-2026)
  3. 3.3 Global Gadobebe Diglumine Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Gadobebe Diglumine Injection Average Price by Company (2021-2026)
  5. 3.5 Global Gadobebe Diglumine Injection Company Ranking (2024-2026)
  6. 3.6 Global Gadobebe Diglumine Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Gadobebe Diglumine Injection Company Product Type and Application
  8. 3.8 Global Gadobebe Diglumine Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gadobebe Diglumine Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gadobebe Diglumine Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gadobebe Diglumine Injection Market by Type
  1. 4.1 Gadobebe Diglumine Injection Type Introduction
  2. 4.1.1 20ml
  3. 4.1.2 15ml
  4. 4.1.3 10ml
  5. 4.2 Global Gadobebe Diglumine Injection Sales Volume by Type
  6. 4.2.1 Global Gadobebe Diglumine Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gadobebe Diglumine Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Gadobebe Diglumine Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Gadobebe Diglumine Injection Sales Value by Type
  10. 4.3.1 Global Gadobebe Diglumine Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Gadobebe Diglumine Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Gadobebe Diglumine Injection Sales Value Share by Type (2021-2032)
5 Gadobebe Diglumine Injection Market by Application
  1. 5.1 Gadobebe Diglumine Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Gadobebe Diglumine Injection Sales Volume by Application
  6. 5.2.1 Global Gadobebe Diglumine Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gadobebe Diglumine Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gadobebe Diglumine Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gadobebe Diglumine Injection Sales Value by Application
  10. 5.3.1 Global Gadobebe Diglumine Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gadobebe Diglumine Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gadobebe Diglumine Injection Sales Value Share by Application (2021-2032)
6 Gadobebe Diglumine Injection Regional Sales and Value Analysis
  1. 6.1 Global Gadobebe Diglumine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gadobebe Diglumine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Gadobebe Diglumine Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Gadobebe Diglumine Injection Sales by Region (2027-2032)
  5. 6.3 Global Gadobebe Diglumine Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gadobebe Diglumine Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gadobebe Diglumine Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gadobebe Diglumine Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Gadobebe Diglumine Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gadobebe Diglumine Injection Sales Value (2021-2032)
  12. 6.6.2 North America Gadobebe Diglumine Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gadobebe Diglumine Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Gadobebe Diglumine Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gadobebe Diglumine Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gadobebe Diglumine Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gadobebe Diglumine Injection Sales Value (2021-2032)
  21. 6.9.2 South America Gadobebe Diglumine Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gadobebe Diglumine Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gadobebe Diglumine Injection Sales Value Share by Country, 2025 VS 2032
7 Gadobebe Diglumine Injection Country-level Sales and Value Analysis
  1. 7.1 Global Gadobebe Diglumine Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gadobebe Diglumine Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gadobebe Diglumine Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Gadobebe Diglumine Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Gadobebe Diglumine Injection Sales by Country (2027-2032)
  6. 7.4 Global Gadobebe Diglumine Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gadobebe Diglumine Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gadobebe Diglumine Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gadobebe Diglumine Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gadobebe Diglumine Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gadobebe Diglumine Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Guerbet
  2. 8.1.1 Guerbet Company Information
  3. 8.1.2 Guerbet Business Overview
  4. 8.1.3 Guerbet Gadobebe Diglumine Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Guerbet Gadobebe Diglumine Injection Product Portfolio
  6. 8.1.5 Guerbet Recent Developments
  7. 8.2 Bracco Imaging S.P.A.
  8. 8.2.1 Bracco Imaging S.P.A. Company Information
  9. 8.2.2 Bracco Imaging S.P.A. Business Overview
  10. 8.2.3 Bracco Imaging S.P.A. Gadobebe Diglumine Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bracco Imaging S.P.A. Gadobebe Diglumine Injection Product Portfolio
  12. 8.2.5 Bracco Imaging S.P.A. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gadobebe Diglumine Injection Value Chain Analysis
  2. 9.1.1 Gadobebe Diglumine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gadobebe Diglumine Injection Sales Mode & Process
  6. 9.2 Gadobebe Diglumine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gadobebe Diglumine Injection Distributors
  9. 9.2.3 Gadobebe Diglumine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst